Search Results - Esther Meijer

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD by Paul Geertsema, Darius Soonawala, Ron T. Gansevoort, Esther Meijer

    Published in Kidney International Reports (2025-01-01)
    Get full text
    Article


  2. 2

    Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease by A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard, Esther Meijer, on behalf of the DIPAK Consortium

    Published in BMC Nephrology (2018-12-01)
    Get full text
    Article


  3. 3

    Family Planning in Patients With ADPKD–Results From the DIPAK Consortium by Willemijn A.L. Vrijlandt, Thomas Bais, Lisa Margot Vijn-Villalever, Stefan P. Berger, Esther Meijer, Ron T. Gansevoort, Margriet F.C. de Jong, J.P.H. Drenth, J.W. de Fijter, D.J.M. Peters, M. Salih, E.J. Hoorn, T. Nijenhuis

    Published in Kidney International Reports (2025-06-01)
    Get full text
    Article


  4. 4

    HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized co... by Thomas Bais, Esther Meijer, Bart J. Kramers, Priya Vart, Marc Vervloet, Mahdi Salih, Bert Bammens, Nathalie Demoulin, Polina Todorova, Roman-Ulrich Müller, Jan Halbritter, Alexander Paliege, Emilie Cornec-Le Gall, Bertrand Knebelmann, Roser Torra, Albert C. M. Ong, Fiona E. Karet Frankl, Ron T. Gansevoort

    Published in Trials (2024-02-01)
    Get full text
    Article


Search Tools: